Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics such as antibody drug conjugates, bispecific antibodies and overcoming the blood-brain barrier. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment.

Sessions for the Conference:

• Novel Antibody Targets
•  Antibody Selection Methods & Strategies
• Bispecific Antibodies & Fusion Proteins
• Immunomodulatory Biotherapy for Cancer
• Next Generation of Protein Engineering
• Combining Antibody Therapeutics